15 reports of this reaction
2.6% of all CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE reports
#7 most reported adverse reaction
EXPIRED PRODUCT ADMINISTERED is the #7 most commonly reported adverse reaction for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, manufactured by Bausch Health US, LLC. There are 15 FDA adverse event reports linking CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE to EXPIRED PRODUCT ADMINISTERED. This represents approximately 2.6% of all 579 adverse event reports for this drug.
Patients taking CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE who experience expired product administered should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
EXPIRED PRODUCT ADMINISTERED is a less commonly reported adverse event for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, but still significant enough to appear in the safety profile.
In addition to expired product administered, the following adverse reactions have been reported for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE:
The following drugs have also been linked to expired product administered in FDA adverse event reports:
EXPIRED PRODUCT ADMINISTERED has been reported as an adverse event in 15 FDA reports for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
EXPIRED PRODUCT ADMINISTERED accounts for approximately 2.6% of all adverse event reports for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, making it a notable side effect.
If you experience expired product administered while taking CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.